• 

  May 6, 2025

  Quris Technologies Demonstrates Liver-Driven Brain Toxicity in New Multi-Organ Model

  R.D. Solorzano

• 

  April 8, 2025

  Xylyx Bio Secures $1.125 Million to Advance Innovations in Xenogeneic Cross-Circulation Transplant Organs

  R.D. Solorzano

• 

  February 6, 2025

  EU-Funded micro2MACRO Project Aims to Push Cartilage Tissue Regeneration with Bioprinting

  R.D. Solorzano

• 

  February 6, 2025

  Auxilium Biotechnologies Achieves Bioprinting Milestone Aboard the ISS

  R.D. Solorzano

• 

  February 4, 2025

  Handheld Bioprinting with Kombucha-Based Bioink

  R.D. Solorzano

• 

  February 1, 2025

  Time Code: Improved Printing Code for 3D Bioprinting

  R.D. Solorzano

• 

  February 1, 2025

  MEDELLAPRO®: Endotoxin-Controlled Bioprinting Materials

  R.D. Solorzano

• 

  January 27, 2025

  Further Unlocking the Potential of 4D Bioprinting for Heart Tissue Engineering

  R.D. Solorzano

• 

  December 13, 2024

  JOIN C-STARS: Exploring the Future of Space BioFabrication and Manufacturing

  R.D. Solorzano

• 

  December 2, 2024

  Engineering the Future of Vascularized Tissues: Programmable Bioinks Take Center Stage

  R.D. Solorzano